Next 10 |
2024-06-17 12:00:11 ET Frank Takkinen from Loop Capital Markets issued a price target of $60.00 for IRMD on 2024-06-17 09:49:00. The adjusted price target was set to $60.00. At the time of the announcement, IRMD was trading at $43.285. IRMD currently trades -15.48% versu...
2024-06-17 11:15:03 ET Lake Street analyst issues BUY recommendation for IRMD on June 17, 2024 09:49AM ET. The previous analyst recommendation was Buy. IRMD was trading at $43.285 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 ...
2024-06-07 09:16:45 ET More on iRadimed iRadimed resumed at Roth MKM as a buy as only provider of MRI-compatible IV pumps Seeking Alpha’s Quant Rating on iRadimed Read the full article on Seeking Alpha For further details see: Iradimed uplists to N...
WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today its common stock will uplist and commence trading on the Nasdaq Glo...
2024-05-04 13:27:07 ET IRADIMED CORPORATION (IRMD) Q1 2024 Results Conference Call May 02, 2024 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Jack Glenn - Chief Financial Officer Conference Call Participants Jason Wit...
2024-05-02 12:53:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips iRadimed (NASDAQ: IRMD ) just reported results for the first quarter of 2024. iRadimed reported earnings per share of 36 cents. This was above the analyst estimate for EPS...
2024-05-02 08:46:20 ET More on iRadimed IRadimed Corporation (IRMD) Q4 2023 Earnings Call Transcript iRadimed Q1 2024 Earnings Preview iRadimed resumed at Roth MKM as a buy as only provider of MRI-compatible IV pumps Seeking Alpha’s Quant Rating on iRa...
2024-05-02 08:41:32 ET More on iRadimed IRadimed Corporation (IRMD) Q4 2023 Earnings Call Transcript iRadimed Q1 2024 Earnings Preview iRadimed resumed at Roth MKM as a buy as only provider of MRI-compatible IV pumps Seeking Alpha’s Quant Rating on iRa...
Reports record revenue of $17.6 million for the first quarter of 2024. Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024. Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared to the same period...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-17 12:00:11 ET Frank Takkinen from Loop Capital Markets issued a price target of $60.00 for IRMD on 2024-06-17 09:49:00. The adjusted price target was set to $60.00. At the time of the announcement, IRMD was trading at $43.285. IRMD currently trades -15.48% versu...
2024-06-17 11:15:03 ET Lake Street analyst issues BUY recommendation for IRMD on June 17, 2024 09:49AM ET. The previous analyst recommendation was Buy. IRMD was trading at $43.285 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 ...
WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today its common stock will uplist and commence trading on the Nasdaq Glo...